Breastfeeding in relation to risk of different breast cancer characteristics

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Butt, Salma ^a   Borgquist, Signe ^a   Anagnostaki, Lola ^a   Landberg, Göran ^a   Manjer, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer risk; Breastfeeding; Characteristics; Stage

Indexed keywords

CYCLIN D1; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; KI 67 ANTIGEN; P27 ANTIGEN; TUMOR MARKER;

ADULT; AGED; BREAST FEEDING; BREAST NEOPLASMS; CANCER GRADING; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SWEDEN; TIME;

ADULT; AGED; BREAST FEEDING; BREAST NEOPLASMS; CYCLIN D1; FEMALE; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; PROLIFERATING CELL NUCLEAR ANTIGEN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RISK FACTORS; SWEDEN; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899480383     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-216     Document Type: Article

References (29)

1. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Collaborative Group on Hormonal Factors in Breast Cancer, Lancet 2002 360 9328 187 195 12133652
2. A systematic review of the association between breastfeeding and breast cancer. Yang L, Jacobsen KH, J Womens Health (Larchmt) 2008 17 10 1635 1645 10.1089/jwh.2008.0917 19049358
3. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Ma H, Bernstein L, Pike MC, Ursin G, Breast Cancer Res 2006 8 4 43 10.1186/bcr1525 16859501
4. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI, Cancer 2008 113 7 1521 1526 10.1002/cncr.23786 18726992
5. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R, Br J Cancer 2005 93 3 364 371 10.1038/sj.bjc.6602712 16079783
6. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Manjer J, Carlsson S, Elmståhl S, Gullberg B, Janzon L, Lindström M, Mattisson I, Berglund G, Eur J Cancer Prev 2001 10 6 489 499 10.1097/00008469-200112000-00003 11916347
7. Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Manjer J, Elmstahl S, Janzon L, Berglund G, Scand J Public Health 2002 30 2 103 112 10.1177/14034948020300020401 12028859
8. The protective role of pregnancy in breast cancer. Russo J, Moral R, Balogh GA, Mailo D, Russo IH, Breast Cancer Res 2005 7 3 131 142 10.1186/bcr1029 15987443
9. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Elston CW, Ellis IO, Histopathology 1991 19 5 403 410 10.1111/j.1365-2559.1991.tb00229.x 1757079
10. Breast tumours following combined hormone replacement therapy express favourable prognostic factors. Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J, Int J Cancer 2007 120 10 2202 2207 10.1002/ijc.22542 17278089
11. Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators. Borgquist S1, Wirfält E, Jirström K, Anagnostaki L, Gullberg B, Berglund G, Manjer J, Landberg G, Breast Cancer Res 2007 9 1 11 10.1186/bcr1644 17254341
12. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE, J Pathol 2003 199 4 418 423 10.1002/path.1313 12635131
13. Self-reported birthweight and history of having been breastfed among younger women: an assessment of validity. Troy LM, Michels KB, Hunter DJ, Spiegelman D, Manson JE, Colditz GA, Stampfer MJ, Willett WC, Int J Epidemiol 1996 25 1 122 127 10.1093/ije/25.1.122 8666479
14. Breast-feeding, children born 2006. SoS (The National Board of Health and Welfare in Sweden), 2006 [ http://www.socialstyrelsen.se/publikationer2008/ 2008-125-12 ]
15. Garne JP, Invasive breast cancer in Malmö 1961-1992-an epidemiological study. Dissertation Malmö: Lund University 1996
16. Breast irradiation and lactation: a review. Leal SC, Stuart SR, Carvalho Hde A, Expert Rev Anticancer Ther 2013 13 2 159 164 10.1586/era.12.178 23406557
17. Nonattendance in mammographic screening: a study of intraurban differences in Malmo, Sweden, 1990-1994. Matson S, Andersson I, Berglund G, Janzon L, Manjer J, Cancer Detect Prev 2001 25 2 132 137 11341348
18. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Zackrisson S, Andersson I, Manjer J, Janzon L, Int J Cancer 2004 108 5 754 760 10.1002/ijc.11622 14696103
19. Validation of tissue microarray technology in breast carcinoma. Camp RL, Charette LA, Rimm DL, Lab Invest 2000 80 12 1943 1949 10.1038/labinvest.3780204 11140706
20. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Hoos A, Cordon-Cardo C, Lab Invest 2001 81 10 1331 1338 10.1038/labinvest.3780347 11598146
21. Parity and age at first childbirth in relation to the risk of different breast cancer subgroups. Butt S, Borgquist S, Anagnostaki L, Landberg G, Manjer J, Int J Cancer 2009 125 8 1926 1934 10.1002/ijc.24494 19569233
22. Variables associated with breastfeeding duration. Thulier D, Mercer J, J Obstet Gynecol Neonatal Nurs 2009 38 3 259 268 10.1111/j.1552-6909.2009.01021.x 19538614
23. Toward a physiological approach to breast cancer prevention. Russo J, Russo IH, Cancer Epidemiol Biomarkers Prev 1994 3 4 353 364 8061586
24. Epidemiology of endocrine-related risk factors for breast cancer. Bernstein L, J Mammary Gland Biol Neoplasia 2002 7 1 3 15 10.1023/A: 1015714305420 12160084
25. Do regular ovulatory cycles increase breast cancer risk? Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC, Cancer 1985 56 5 1206 1208 10.1002/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO;2-9 4016708
26. Prolactin and breast cancer risk. Tworoger SS, Hankinson SE, Cancer Lett 2006 243 2 160 169 10.1016/j.canlet.2006.01.032 16530327
27. Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Hietala M, Olsson H, Jernstrom H, Fam Cancer 2008 7 3 221 228 10.1007/s10689-007-9178-0 18080788
28. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE, Am J Pathol 1995 146 3 695 705 7534043
29. Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer. Borgquist S, Jirstrom K, Anagnostaki L, Manjer J, Landberg G, Int J Cancer 2009 124 2 402 411 10.1002/ijc.23850 18798278